| Autor: |
Ghoshal, Kakali, Luther, James M., Pakala, Suman B., Chetyrkin, Sergei, Falck, John R., Zent, Roy, Wasserman, David H., Pozzi, Ambra |
| Předmět: |
|
| Zdroj: |
Diabetes; Aug2024, Vol. 73 Issue 8, p1229-1243, 15p |
| Abstrakt: |
Cytochrome P450 epoxygenase Cyp2c44, a murine epoxyeicosatrienoic acid (EET)-producing enzyme, promotes insulin sensitivity, and Cyp2c44 −/− mice show hepatic insulin resistance. Because insulin resistance leads to hepatic lipid accumulation and hyperlipidemia, we hypothesized that Cyp2c44 regulates hepatic lipid metabolism. Standard chow diet (SCD)-fed male Cyp2c44 −/− mice had significantly decreased EET levels and increased hepatic and plasma lipid levels compared with wild-type mice. We showed increased hepatic plasma membrane localization of the FA transporter 2 (FATP2) and total unsaturated fatty acids and diacylglycerol (DAG) levels. Cyp2c44 −/− mice had impaired glucose tolerance and increased hepatic plasma membrane–associated PKCδ and phosphorylated IRS-1, two negative regulators of insulin signaling. Surprisingly, SCD and high-fat diet (HFD)-fed Cyp2c44 −/− mice had similar glucose tolerance and hepatic plasma membrane PKCδ levels, suggesting that SCD-fed Cyp2c44 −/− mice have reached their maximal glucose intolerance. Inhibition of PKCδ resulted in decreased IRS-1 serine phosphorylation and improved insulin-mediated signaling in Cyp2c44 −/− hepatocytes. Finally, Cyp2c44 −/− HFD-fed mice treated with the analog EET-A showed decreased hepatic plasma membrane FATP2 and PCKδ levels with improved glucose tolerance and insulin signaling. In conclusion, loss of Cyp2c44 with concomitant decreased EET levels leads to increased hepatic FATP2 plasma membrane localization, DAG accumulation, and PKCδ-mediated attenuation of insulin signaling. Thus, Cyp2c44 acts as a regulator of lipid metabolism by linking it to insulin signaling. Article Highlights: Loss of epoxygenase Cyp2c44 leads to glucose intolerance, characterized by an increase in hepatic lipids and hyperlipidemia. Cyp2c44 participates in the regulation of hepatic fatty acid accumulation by limiting the plasma membrane localization of FATP2 and, in turn, intracellular levels of diacylglycerol. Cyp2c44-mediated downregulation of intracellular diacylglycerol levels results in decreased plasma membrane–associated PKCδ and phosphorylated IRS-1, two negative regulators of insulin signaling. Thus, Cyp2c44 acts as a regulator of lipid metabolism by linking it to insulin signaling. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
